Cardiol Therapeutics Inc.Cardiol Therapeutics Inc.Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

No trades
See on Supercharts

Price target

8.650.000.00%
The 5 analysts offering 1 year price forecasts for CRDL have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to CRDL in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CRDL EPS for the last quarter is −0.07 USD despite the estimation of −0.10 USD. In the next quarter EPS is expected to reach −0.09 USD. Track more of Cardiol Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Cardiol Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Cardiol Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, CRDL price target is 8.65 USD with a max estimate of 9.94 USD and a min estimate of 7.91 USD. Check if this forecast comes true in a year, meanwhile watch Cardiol Therapeutics Inc. stock price chart and keep track of the current situation with CRDL news and stock market news.
We've gathered opinions of 5 analysts rating CRDL stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.